SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (1975)8/14/1997 10:09:00 PM
From: Cytokine1   of 9719
 
TECH--Techne Corp:

I am a previous owner of this stock at $17, sold too early at $20. Was impressed with the consistent earnings and that they had a significant position as a provider of biotech raw materials (dare I say "cytokines"?) to other companies for research purposes. They also make hemotology calibrators and controls.

Techne has zero LT debt, just reported FY (June) earnings of 1.12 (beating estimates of 1.08), a 26% increase from last year. 46% of the stock is held by institutions. Five-year revenue growth over 20%, and earnings growth over 30%. About 9.5M shares outstanding. Investor's Business Daily EPS rank of 92.

-------------1997 1996 1995 1994 1993 1992

SALES........... 60.9 54.6 47.7 40.3 28.7 22.3

EARNINGS..... 1.12 .89 .70 .54 .46 .21

PROFIT MAR... 17.9% 15.8% 14% 12.7% 15.3% 9%

P/E................ 27 33 19 19 32 43
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News